UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Quant / Systematic

CIK: 0001019231 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value ($000): $72,490 (100.0% shares, 0.0% debt)

Holdings (9)

SPY SPDR TRUST SERIES 1 72.7%

Value ($000) $52,696 Shares 204,446 Est. Cost $263.15 Unrealized —

VT VANGUARD TOTAL WORLD STOCK ETF 15.7%

Value ($000) $11,402 Shares 181,558 Est. Cost $80.77 Unrealized —

— SOLITON INC 4.7%

Value ($000) $3,443 Shares 425,000 Est. Cost $10.98 Unrealized —

TXN TEXAS INSTRUMENTS INC 4.4%

Value ($000) $3,198 Shares 32,000 Est. Cost $57.24 Unrealized +77.6%

— AEGLEA BIOTHERAPEUTICS INC 2.1%

Value ($000) $1,504 Shares 322,658 Est. Cost $6.41 Unrealized —

— PLX PHARMA INC 0.2%

Value ($000) $141 Shares 62,673 Est. Cost $6.14 Unrealized —

LXRX LEXICON PHARMACEUTICALS INC 0.1%

Value ($000) $70 Shares 35,714 Est. Cost $7.34 Unrealized -59.5%

— APOLLO ENDOSURGERY INC 0.0%

Value ($000) $30 Shares 15,601 Est. Cost $12.52 Unrealized —

POR PORTLAND GENERAL ELECTRIC CO 0.0%

Value ($000) $6 Shares 118 Est. Cost $20.00 Unrealized +119.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
SPY	SPDR TRUST SERIES 1	204,446	$52,696	72.7%	$263.15	—	ETFS	78462F103
VT	VANGUARD TOTAL WORLD STOCK ETF	181,558	$11,402	15.7%	$80.77	—	ETFS	922042742
—	SOLITON INC	425,000	$3,443	4.7%	$10.98	—	COM	834251100
TXN	TEXAS INSTRUMENTS INC	32,000	$3,198	4.4%	$57.24	+77.6%	COM	882508104
—	AEGLEA BIOTHERAPEUTICS INC	322,658	$1,504	2.1%	$6.41	—	COM	00773J103
—	PLX PHARMA INC	62,673	$141	0.2%	$6.14	—	COM	72942A107
LXRX	LEXICON PHARMACEUTICALS INC	35,714	$70	0.1%	$7.34	-59.5%	COM	528872302
—	APOLLO ENDOSURGERY INC	15,601	$30	0.0%	$12.52	—	COM	03767D108
POR	PORTLAND GENERAL ELECTRIC CO	118	$6	0.0%	$20.00	+119.2%	COM	736508847